477 related articles for article (PubMed ID: 10908610)
1. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.
Lim GP; Yang F; Chu T; Chen P; Beech W; Teter B; Tran T; Ubeda O; Ashe KH; Frautschy SA; Cole GM
J Neurosci; 2000 Aug; 20(15):5709-14. PubMed ID: 10908610
[TBL] [Abstract][Full Text] [Related]
2. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.
Morihara T; Teter B; Yang F; Lim GP; Boudinot S; Boudinot FD; Frautschy SA; Cole GM
Neuropsychopharmacology; 2005 Jun; 30(6):1111-20. PubMed ID: 15688088
[TBL] [Abstract][Full Text] [Related]
3. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.
Lim GP; Chu T; Yang F; Beech W; Frautschy SA; Cole GM
J Neurosci; 2001 Nov; 21(21):8370-7. PubMed ID: 11606625
[TBL] [Abstract][Full Text] [Related]
4. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
[TBL] [Abstract][Full Text] [Related]
5. Ibuprofen and Alzheimer's disease.
Dokmeci D
Folia Med (Plovdiv); 2004; 46(2):5-10. PubMed ID: 15506544
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
[TBL] [Abstract][Full Text] [Related]
7. Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.
Jantzen PT; Connor KE; DiCarlo G; Wenk GL; Wallace JL; Rojiani AM; Coppola D; Morgan D; Gordon MN
J Neurosci; 2002 Mar; 22(6):2246-54. PubMed ID: 11896164
[TBL] [Abstract][Full Text] [Related]
8. CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease.
Imbimbo BP; Hutter-Paier B; Villetti G; Facchinetti F; Cenacchi V; Volta R; Lanzillotta A; Pizzi M; Windisch M
Br J Pharmacol; 2009 Mar; 156(6):982-93. PubMed ID: 19239474
[TBL] [Abstract][Full Text] [Related]
9. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain.
Welikovitch LA; Do Carmo S; Maglóczky Z; Malcolm JC; Lőke J; Klein WL; Freund T; Cuello AC
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6844-6854. PubMed ID: 32144141
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory treatment in AD mice protects against neuronal pathology.
Choi JK; Jenkins BG; Carreras I; Kaymakcalan S; Cormier K; Kowall NW; Dedeoglu A
Exp Neurol; 2010 Jun; 223(2):377-84. PubMed ID: 19679126
[TBL] [Abstract][Full Text] [Related]
11. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
Zhang C; Griciuc A; Hudry E; Wan Y; Quinti L; Ward J; Forte AM; Shen X; Ran C; Elmaleh DR; Tanzi RE
Sci Rep; 2018 Jan; 8(1):1144. PubMed ID: 29348604
[TBL] [Abstract][Full Text] [Related]
12. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.
Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW
J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology.
Münch G; Apelt J; Rosemarie-Kientsch-Engel ; Stahl P; Lüth HJ; Schliebs R
J Neurochem; 2003 Jul; 86(2):283-9. PubMed ID: 12871569
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
15. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
[TBL] [Abstract][Full Text] [Related]
16. Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice.
MacPherson KP; Sompol P; Kannarkat GT; Chang J; Sniffen L; Wildner ME; Norris CM; Tansey MG
Neurobiol Dis; 2017 Jun; 102():81-95. PubMed ID: 28237313
[TBL] [Abstract][Full Text] [Related]
17. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
van Groen T; Miettinen P; Kadish I
J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
[TBL] [Abstract][Full Text] [Related]
18. Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice.
Lim GP; Yang F; Chu T; Gahtan E; Ubeda O; Beech W; Overmier JB; Hsiao-Ashec K; Frautschy SA; Cole GM
Neurobiol Aging; 2001; 22(6):983-91. PubMed ID: 11755007
[TBL] [Abstract][Full Text] [Related]
19. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
[TBL] [Abstract][Full Text] [Related]
20. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.
Mehlhorn G; Hollborn M; Schliebs R
Int J Dev Neurosci; 2000; 18(4-5):423-31. PubMed ID: 10817926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]